Immunization-history-search
{
{
{
{
"display": "Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure)"
}
]
}
}
],
{
}
],
{
"display": "COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)"
}
]
},
}
},
},
{
}
]
},
},
{
}
}
}
],
{
]
}
],
]
},
}
},
{
{
{
"display": "Administration of second dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure)"
}
]
}
}
],
{
}
],
{
"display": "COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)"
}
]
},
}
},
},
},
{
}
]
},
},
{
}
}
}
],
{
]
}
],
]
},
}
}
]
}
<Immunization>
<display value="Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure)" />
</coding>
</valueCodeableConcept>
</extension>
</identifier>
<display value="COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" />
</coding>
</vaccineCode>
</identifier>
</patient>
</manufacturer>
</coding>
</route>
</doseQuantity>
</identifier>
</actor>
</performer>
</coding>
</reasonCode>
</protocolApplied>
</Immunization>
</resource>
</search>
</entry>
<Immunization>
<display value="Administration of second dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure)" />
</coding>
</valueCodeableConcept>
</extension>
</identifier>
<display value="COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" />
</coding>
</vaccineCode>
</identifier>
</patient>
</reportOrigin>
</manufacturer>
</coding>
</route>
</doseQuantity>
</identifier>
</actor>
</performer>
</coding>
</reasonCode>
</protocolApplied>
</Immunization>
</resource>
</search>
</entry>
</Bundle>
Bundle |
id : dd4c3e37-555d-47fc-9309-37539893e074 |
type : searchset |
total : 2 |
entry |
fullUrl : Immunization/edea022a-2d81-11eb-adc1-0242ac120001 |
resource |
id : edea022a-2d81-11eb-adc1-0242ac120001 |
extension |
url : https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure |
value |
coding |
system : http://snomed.info/sct |
code : 1324681000000101 |
display : Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure) |
identifier |
use : secondary |
system : https://supplierABC/identifiers/vacc |
value : 1324761000000100 |
status : completed |
vaccineCode |
coding |
system : http://snomed.info/sct |
code : 39114911000001105 |
display : COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) |
patient |
type : Patient |
identifier |
system : https://fhir.nhs.uk/Id/nhs-number |
value : 9912003888 |
occurrence : 2020-12-23T13:00:08.476+00:00 |
recorded : 2020-12-23 |
primarySource : True |
manufacturer |
display : AstraZeneca Ltd |
lotNumber : R04X |
expirationDate : 2021-04-29 |
route |
coding |
system : http://snomed.info/sct |
code : 78421000 |
display : Intramuscular route (qualifier value) |
doseQuantity |
value : 0.3 |
unit : mL |
system : http://snomed.info/sct |
code : 258773002 |
performer |
actor |
type : Organization |
identifier |
system : https://fhir.nhs.uk/Id/ods-organization-code |
value : RX809 |
reasonCode |
coding |
system : http://snomed.info/sct |
code : 443684005 |
display : Disease outbreak (event) |
protocolApplied |
doseNumber : 1 |
search |
mode : match |
entry |
fullUrl : Immunization/edea022a-2d81-11eb-adc1-0242ac120000 |
resource |
id : edea022a-2d81-11eb-adc1-0242ac120000 |
extension |
url : https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure |
value |
coding |
system : http://snomed.info/sct |
code : 1324691000000104 |
display : Administration of second dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure) |
identifier |
use : secondary |
system : https://supplierABC/identifiers/vacc |
value : 1324761000000102 |
status : completed |
vaccineCode |
coding |
system : http://snomed.info/sct |
code : 39114911000001105 |
display : COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) |
patient |
type : Patient |
identifier |
system : https://fhir.nhs.uk/Id/nhs-number |
value : 9912003888 |
occurrence : 2021-02-23T13:00:08.476+00:00 |
recorded : 2021-02-23 |
primarySource : False |
reportOrigin |
text : RR8 - LEEDS TEACHING HOSPITALS NHS TRUST |
manufacturer |
display : AstraZeneca Ltd |
lotNumber : A04Z |
expirationDate : 2021-06-29 |
route |
coding |
system : http://snomed.info/sct |
code : 78421000 |
display : Intramuscular route (qualifier value) |
doseQuantity |
value : 0.3 |
unit : mL |
system : http://snomed.info/sct |
code : 258773002 |
performer |
actor |
type : Organization |
identifier |
system : https://fhir.nhs.uk/Id/ods-organization-code |
value : RX809 |
reasonCode |
coding |
system : http://snomed.info/sct |
code : 443684005 |
display : Disease outbreak (event) |
protocolApplied |
doseNumber : 2 |
search |
mode : match |